CA Omkar Bhutada - SEBI Reg IA
29 Apr • 3:30 PM · SEBI-Registered Analyst
Strong post-accumulation breakout, but structurally a bit more explosive
Lincoln Pharmaceuticals Ltd. Share Price
Overview
Lincoln Pharmaceuticals Ltd. share price is currently ₹504.34, down by - ₹1.13 (0.22%) from its previous closing price of ₹505.47. The share price has declined -14.4% over the past month and declined -3.4% over the past year. The stock's 52-week low and high are ₹436.66 and ₹758.14, respectively. Lincoln Pharmaceuticals Ltd. has a market capitalisation of ₹ 1,090.00 Cr. The share price was last updated on 23 Oct 2026, 09:37 AM IST.
Updated: 23 Oct 2026, 09:37:23 am IST
Market Data
Open Price
₹508.82Prev. Close
₹505.47Day Low
Day High
52 Week Low
52 Week High
Fundamentals
Quick Bite
Price To Earnings Ratio
10.47Sector PE
41.82PB Ratio
1.33Sector PB
5.48EPS
48.15Dividend Yield
0.32Today's Volume
1.671 K5 Day Avg. Volume
30.838 KPEG Ratio
1.55Market Cap.
₹ 1,090.00 Cr.StockGro Trade views
Technical Analysis
Forecasts 🧭
Financials
Corporate Actions
Mutual Fund Ownership
Mutual Fund Holder | Aug 26 Shares held | Sep 26 Shares held |
|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 264 | 268 (1.52%) |
| Bandhan BSE Healthcare Index Fund - Regular Plan - Growth | 124 | 126 (1.61%) |
About Lincoln Pharmaceuticals Ltd. 👋
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company's product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women's healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.
Expert Opinions
Insights from SEBI-registered analysts · updated live
Rajneesh Sharma CFTe
12 Feb • 5:30 PM · SEBI-Registered Analyst
Lincoln Pharmaceuticals Ltd (Weekly Chart): Descending Channel Breakout Near ₹615 Resistance with RSI Momentum Shift
Chahat Aggrawal
12 Feb • 5:23 PM · SEBI-Registered Analyst
Lincoln Pharma Q3FY26: PAT Jumps 37.7%, Revenue Up 13%
💊
Chahat Aggrawal
10 Jan • 9:00 PM · SEBI-Registered Analyst
Lincoln Pharmaceuticals Secures CRISIL A/Stable Rating
🏥 CRISIL has reaffirmed
Ashish Kumar
15 Feb • 1:27 PM · SEBI-Registered Analyst
Small-Cap Stocks Take a Hit as BSE Index Dips
The BSE Small-cap index has seen a significant decline, dropping 9.5 percent. This downturn has affected a large number of stocks, with over 450 experiencing losses between 10 and 41 percent.
Several companies have been particularly hard hit, with shares falling between 25 and 41 percent. These include NGL Fine Chem,
Vibhu Jain
3 Dec • 2:40 PM · SEBI-Registered Analyst
The stock market is constantly evolving
The stock market is constantly evolving and today, the small cap segment has caught the attention of investors. According to the latest market summary, the BSE Smallcap index has seen a rise of 0.97% and in the last 5 days, it has surged by 3.01%. This makes it the best performing segment across MCaps. Among the top performers in this segment is Lincoln Pharma, with a return of 19.74%. On the other hand, C.E. Info System has been the worst performer with a return of -8.78%. This shows the volatility of the small cap market, where gains and losses can be significant. The advance decline ratio of stocks in this segment is also noteworthy, with 688 stocks advancing and 251 stocks declining. This translates to a ratio of 2.74x, indicating a positive trend in the small cap market. Investors should also take note of the recent upgrades in stock scores for some companies in this segment. Cosmo First, Gabriel India, NCC, AGI Greenpac, and Affle India have all been upgraded from Hold to Buy. This suggests that these stocks have the potential to perform well in the near future. With the small cap segment showing promising growth and potential, investors should keep a close eye on these stocks and make informed decisions to capitalize on the current market trend.
See MoreNews & Events
Frequently Asked Questions
What is the share price of Lincoln Pharmaceuticals Ltd.?
What is the market cap of Lincoln Pharmaceuticals Ltd.?
Should I buy Lincoln Pharmaceuticals Ltd. stock now?
What is the 52 week high and low of Lincoln Pharmaceuticals Ltd.?
Is the Lincoln Pharmaceuticals Ltd. stock good to buy?
Is Lincoln Pharmaceuticals Ltd. a good buy for the long term?
Is Lincoln Pharmaceuticals Ltd. overvalued or undervalued?
What is the PE and PB ratio of Lincoln Pharmaceuticals Ltd.?
Today's market leaders and laggards
JSW Dulux Ltd.
JSWDULUX
₹285.98
+30.11 (11.77%)
Cyient Ltd.
CYIENT
₹1,244.43
+111.50 (9.84%)
Jyoti Structures Ltd.
JYOTISTRUC
₹8.38
+0.48 (6.08%)
Kriti Industries (India) Ltd.
KRITI
₹53.16
+3.45 (6.94%)
Jindal Poly Films Ltd.
JINDALPOLY
₹716.77
+47.69 (7.13%)